Ads
related to: survival food companies list
Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoPfizer also recently said its new drug, Adcetris, improved overall survival, progression-free ...
14 TV stars from around the Wiregrass
WTVY Dothan· 6 hours agoThe Wiregrass area and surrounding cities are filled with talent. You might recognize some of these faces from your favorite reality, cooking, survival...
Promising HPV Cancer Treatment Advances in Clinical Trial By Investing.com
Investing.com· 4 days agoHOOKIPA Pharma Inc. (NASDAQ: HOOK), a clinical-stage biopharmaceutical company, has reported...
DermaSensor COO on bringing skin cancer detection device to market - South Florida Business Journal
The Business Journals· 3 days agoAfter years of development, DermaSensor's handheld skin cancer detection tool is now in the hands of...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 3 days agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Main Street Ventures awards first grants of 2024 to Mimi’s Macros, Almost V’Gan, Common Kin -...
The Business Journals· 2 days agoThe 12 recipients, which include a restaurant opening soon in downtown Cincinnati and a local meal...
Bob's discount campaign
Politico· 4 days agoCatalini: “New Jersey proposed Monday removing the bald eagle from its endangered species list, citing a rebound since more than four decades ago, when a single nesting pair ...
A Lesson From History: AI Is Not Likely To Kill Jobs
Forbes· 6 days agoAI adoption in businesses is beginning to grow. According to McKinsey’s State of AI in Early 2024 survey, which was released last week, nearly three quarters of U.S. businesses are now using ...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 5 days agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result after the company
NIAID funds second year of Pluri's radiation therapy studies By Investing.com
Investing.com· 2 days agoPluri Inc. (NASDAQ:PLUR) (TASE:PLUR), a biotechnology firm, has received continued funding from the...
